A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
Recruiting · NCT06630234 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT06630234 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Deciphera Pharmaceuticals, LLC | 15 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| HonorHealth | Scottsdate | United States | 1 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| START Midwest | Grand Rapids | United States | 79 |
| UC San Diego Moores Cancer Center | La Jolla | United States | 199 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami | United States | 15 |
| Vanderbilt University-Ingram Cancer Center | Nashville | United States | 1 |